title: Long-lasting binding of IT-066 to human histamine H2 receptor.
abstract: Based on animal models, IT-066, a histamine H2-receptor antagonist, is reported to possess potent and long-lasting antagonisms on histamine H2 receptor (H2R) -mediated effects. However, no reports have been published concerning its interaction with the human H2R. The aim of this study is to characterize its interaction with human H2R. Chinese hamster ovary cell lines stably expressing human H2Rs were obtained. The effects of IT-066, famotidine, and ranitidine on tiotidine binding and histamine-stimulated cAMP production were analyzed. IT-066 inhibited [3H]tiotidine binding and histamine-stimulated cAMP production more potently than famotidine or ranitidine. In addition, preincubation with 10(-5) M IT-066, but not with 10(-5) M famotidine or 10(-4) M ranitidine, had marked inhibitory effects long after extensive washing. Paraformaldehyde fixation of the cells blunted inhibition of [3H]tiotidine binding induced by preincubation with IT-066, but not that by preincubation with famotidine or ranitidine. IT-066 has potent and long-lasting antagonisms on human H2R. At least one of the IT-066 binding sites is not shared by famotidine, ranitidine, or tiotidine and is affected by paraformaldehyde fixation.
authors.affiliation: Department of Internal Medicine, Tokyo Women's University School of Medicine Daini Hospital, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Otsuka
authors.forename: Y
authors.initials: Y
authors.lastname: Fukushima
authors.forename: M
authors.initials: M
authors.lastname: Tamai
authors.forename: H
authors.initials: H
authors.lastname: Takahashi
authors.forename: H
authors.initials: H
authors.lastname: Mori
authors.forename: T
authors.initials: T
authors.lastname: Asano
authors.forename: T
authors.initials: T
authors.lastname: Katsube
authors.forename: K
authors.initials: K
authors.lastname: Ogawa
authors.forename: T
authors.initials: T
authors.lastname: Kajiwara
authors.forename: S I
authors.initials: SI
authors.lastname: Ohkawa
authors.forename: T
authors.initials: T
authors.lastname: Saitoh
mesh_terms: D000818:Animals; D000897:Anti-Ulcer Agents / Q000494:pharmacology*; D016466:CHO Cells; D002927:Cimetidine / Q000031:analogs & derivatives / Q000494:pharmacology; D006224:Cricetinae; D000242:Cyclic AMP / Q000096:biosynthesis*; D015738:Famotidine / Q000494:pharmacology; D005404:Fixatives / Q000494:pharmacology; D005557:Formaldehyde / Q000494:pharmacology; D006635:Histamine H2 Antagonists / Q000494:pharmacology*; D010880:Piperidines / Q000494:pharmacology*; D011108:Polymers / Q000494:pharmacology; D011485:Protein Binding / Q000187:drug effects; D011725:Pyridines / Q000494:pharmacology*; D011899:Ranitidine / Q000494:pharmacology; D011970:Receptors, Histamine H2 / Q000187:drug effects*
chemical_list: D000897:Anti-Ulcer Agents; D005404:Fixatives; D006635:Histamine H2 Antagonists; D010880:Piperidines; D011108:Polymers; D011725:Pyridines; D011970:Receptors, Histamine H2; C063924:IT 066; D005557:Formaldehyde; D015738:Famotidine; D002927:Cimetidine; D011899:Ranitidine; D000242:Cyclic AMP; C023990:tiotidine; C003043:paraform